MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Melanoma

This study is currently recruiting participants.
Information provided by Medarex

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Melanoma
			Metastases
2		Additional conditions recognized in this trial
			Neoplasm Metastasis
3		More general conditions related to this trial
			Neoplasms
			Neoplasms by Histologic Type
			Neoplasms, Germ Cell and Embryonal
			Neoplasms, Nerve Tissue
			Neoplastic Processes
			Neuroectodermal Tumors
			Neuroendocrine Tumors
			Nevi and Melanomas
			Pathologic Processes
4		Interventions listed in this trial
			MDX-1379 Melanoma Peptide Vaccine
5		Additional drug interventions recognized in this trial
			Antibodies
			Antibodies, Monoclonal
6		More general drug interventions related to this trial
			Immunologic Factors
			Pharmacologic Actions
			Physiological Effects of Drugs
7		Sponsors listed in this trial
			Medarex